Are Chambal Fertilisers & Chemicals Ltd latest results good or bad?

1 hour ago
share
Share Via
Chambal Fertilisers & Chemicals Ltd's latest results show a year-on-year decline in net sales and profit, but a significant quarter-on-quarter recovery in net profit and improved operating margins indicate effective cost management. Overall, while facing revenue challenges, the company's strong financial health and operational resilience suggest a cautiously optimistic outlook.
Chambal Fertilisers & Chemicals Ltd reported its financial results for the quarter ending June 2026, revealing a complex operational landscape. The company experienced a year-on-year decline in net sales of 11.77%, dropping from ₹5,697.61 crores in June 2025 to ₹5,027.02 crores in the latest quarter. This contraction indicates challenges in maintaining revenue growth amidst heightened competition and regulatory pressures in the fertiliser market.
On the profitability front, the consolidated net profit saw a decrease of 4.62% year-on-year, amounting to ₹523.61 crores compared to ₹548.96 crores in the same quarter of the previous year. However, the company demonstrated significant sequential recovery, with net profit increasing by 209.35% quarter-on-quarter, reflecting the seasonal nature of the fertiliser business, which typically peaks during the monsoon planting period. Operating margins showed resilience, expanding to 16.92%, up from 13.36% in June 2025, which suggests effective cost management and operational efficiency despite the revenue challenges. The company’s return on equity (ROE) stood at 18.77%, indicating strong capital efficiency relative to its peers. Chambal Fertilisers has also seen an adjustment in its evaluation, reflecting the mixed operational performance characterized by strong margin management but ongoing revenue pressures. The company’s balance sheet remains robust, with a significant reduction in debt, enhancing its financial flexibility. In summary, while Chambal Fertilisers is navigating through a challenging revenue environment, its operational resilience and margin expansion highlight its ability to manage costs effectively. The company’s financial health, marked by a strong ROE and improved operating margins, positions it favorably for future growth, albeit with caution regarding market dynamics and regulatory influences.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News